Phẫu thuật nội soi điều trị bệnh lý van ba lá tại Trung tâm Tim mạch, Bệnh viện E

Nguyen Tran Thuy, Hoang Van Trung, Nguyen Cong Huu

Main Article Content

Abstract

Background. Tricuspid regurgitation is one of the most common heart valve diseases, affecting 65-85% of the population. Primary tricuspid regurgitation has causes in the tricuspid valve including rheumatic, degenerative, congenital, infectious, etc. Secondary tricuspid regurgitation is more common, associated with right ventricular dysfunction, dilated annulus. valves, often secondary to left-sided valve disease (especially mitral valve disease), atrial fibrillation, and pulmonary hypertension. Traditional sternal open surgery has the advantage of being spacious and convenient for technical manipulations, but the method still has many traumas and risks of sternum inflammation. Endoscopic surgery avoids opening the sternum with the advantages of minimizing trauma, eliminating sternitis, being more aesthetic is becoming a trend and is increasingly applied in cardiovascular surgery.


Aims: Evaluation of early and medium-term results of endoscopic surgery for tricuspid valve disease at cardiovascular center, E Hospital


 Method. Cross-sectional descriptive study, data were collected retrospectively and prospectively


Result. From January 2020 to December 2021, we studied 42 patients undergoing endoscopic surgery for tricuspid valve disease, including 13 men (31%), 29 women (69%). Average age is 53.98±12.51 years. The number of patients with tricuspid valve repair and mitral valve replacement surgery was 34 patients, the number of patients with tricuspid valve repair after mitral valve replacement surgery was 4 patients, there were 2 patients with severe tricuspid regurgitation due to infective endocarditis . There was 1 patient with tricuspid valve repair combined with atrial septal defect patching. Immediately after surgery, the proportion of patients with no regurgitation or mild regurgitation of the tricuspid valve was 35 patients (83.3%), moderate regurgitation had 6 patients (14.3%), severe regurgitation had 1 patient (2.4%) ), 41 patients (97.6%) were discharged from hospital, 1 patient (2.4%) died early after surgery. The longest follow-up time was 17 months, the shortest was 6 months, the results were no longer tricuspid regurgitation or mild regurgitation in 37 patients (90.2%), moderate regurgitation in 4 patients (9.8%), there aren’t patients with severe regurgitation of the tricuspid valve or late death.


Conclusion. Endoscopic surgery for the treatment of tricuspid valve disease has good results, aesthetics, few complications.

Article Details

References

[1] Singh JP, Evans JC, Levy D, Larson MG, Freed LA, Fuller DL et al. Prevalence and clinical determinants of mitral, tricuspid, and aortic re- gurgitation (the Framingham Heart Study). Am J Cardiol 1999;83: 897–902.
[2] Taramasso M, Vanermen H, Maisano F, Guidotti A, La Canna G, Alfieri O. The growing clinical importance of secondary tricuspid regurgitation. J Am Coll Cardiol 2012;59:703–10.
[3] Dreyfus GD, Martin RP, Chan KM, Dulguerov F, Alexandrescu C. Functional tricuspid regurgitation: a need to revise our understanding. J Am Coll Cardiol 2015;65:2331–6.
[4] Tornos Mas P, Rodriguez-Palomares JF, Antunes MJ. Secondary tricuspid valve regurgitation: a forgotten entity. Curriculum topic: valvular heart diseases. Heart 2015;101:1840–8.
[5] Parolari A, Barili F, Pilozzi A, Pacini D. Ring or suture annuloplasty for tri-cuspid regurgitation? A meta-analysis review. Ann Thorac Surg 2014;98:2255–63.
[6] Kwak Jae-Jin, Kim Yong-Jin, Min Kyung, Kim Hyun-Kwan (2008), “Development of tricuspid regurgitation late after left-sided valve surgery: Sing-center experience with long-term echocardiography examination”, Am Heart J, Vol 155 (issue 4): pp. 732-7
[7] Bleiweis MS, De Virgilio C, Millikein JC, et al (1996), “Tricuspid valve surgery: 15 years experience”, J Nalt Med Assoc, 88(10), pp. 645-8.
[8] Bernal JM, Morales D, Revuelta C, et al (2005), “Reoperation after tricuspide valve repair”, J Thora Cardiovasc Surg, 130 (2), pp. 498- 503.
[9] Porter A, Shapira Y, Wurzel M, et al (1999), “Tricuspid regurgitation late after mitral valve replacement: Clinical and echocardiographic evaluation”, J Heart Valve Dis, 8 (1), pp. 57-62.
[10] Hồ Huỳnh Quang Trí (2010), Nghiên cứu tiến triển của hở van 3 lá sau phẫu thuật van 2 lá ở người bệnh van tim hậu thấp, Luận án Tiến Sĩ Y Học năm 2010, Đại học Y Dược Tp.HCM.
[11] Dreyfus GD, Corbi PJ, Chan KMJ, Bahrami T (2005), “Secondary tricuspid regurgitation or dilatation: Which should be the criteria for surgical repair ?”, Ann Thorac Surg, 79 (1), pp. 127-132.
[12] Frater R (2001), “Tricuspid insufficiency”, J ThoracCardiovasc Surg, 122 (3), pp. 427-429.
[13] Hoàng Anh Tuấn. Hoàng Quốc Toàn, Phẫu thuật sửa vòng van ba lá trong thay van hai lá tổn thương do thấp, Phẫu thuật tim mạch và lồng ngực, 2 (2012), 14-21
[14] Trương Nguyễn Hoài Linh (2015), Nghiên cứu kết quả các phương pháp sửa van ba lá trong phẫu thuật bệnh van hai lá, Luận văn Tiến sĩ Y học năm 2015, Đại học Y Dược Tp. HCM
[15] Wang Guohua, Sun Zongquan, Xia Jiahong, Deng Yongzhi, Chen Jiajun, Su Gang (2008), “Predictors of secondary tricuspid regurgitation after left-sided valve replacement”, Surg Today publish in Japan, Vol 38 (issue 9), pp. 778-83.
[16] Habib G, Lancellotti P, Antunes MJ, Bongiorni MG,Casalta JP,DelZotti F,Dulgheru R,El Khoury G, Erba PA, Iung B, Miro JM, Mulder BJ, Plonska-Gosciniak E, Price S, Roos- Hesselink J, Snygg-Martin U, Thuny F, Tornos Mas P, Vilacosta I, Zamorano JL. ESC guidelines for the management of infective endocarditis: The task force for the manage- ment of infective endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). European Heart Journal. 2015;36:3075-3128. DOI: 10.1093/eurhe artj/ehv319
[17] Dawood MY, Cheema FH, Ghoreishi M, et al. Contemporary outcomes of operations for tricuspid valve infective endocarditis. Ann Thorac Surg 2015;99:539-46.
[18] Remadi JP, Habib G, Nadji G, Brahim A, Thuny F, Casalta JP, Peltier M, Tribouilloy C. Predictors of death and impact of surgery in Staphylococcus aureus infective endocarditis. The Annals of Thoracic Surgery. 2007;83:1295-1302
[19] Sagie A, Schwammenthal E, Padial LR, et al.: Determinants of functional tricuspid regurgitation in incomplete tricuspid valve closure: Doppler color flow study of 109 patients. J Am Coll Cardiol 1994, 24:446–453.
[20] Carpentier A. Cardiac valve surgery—the “French correction.” JThorac Cardiovasc Surg 1983; 86(3):323 – 337.
[21] Fukuda S, Saracino G, Matsumura Y, et al.: Three-dimensional geometry of the tricuspid annulus in healthy subjects and in patients with functional tricuspid regurgitation: a real-time, 3-dimensional echocardiographic study. Circulation 2006, 114(1 Suppl 1):I492–I498.
[22] Sukmawan R, Watanabe N, Ogasawara Y, et al.: Geometricchanges of tricuspid valve tenting in tricuspid regurgitationsecondary to pulmonary hypertension quantified by novelsystem with transthoracic real-time 3-dimensional echocardiography.J Am Soc Echocardiogr 2007.
[23] Deloche A., Guerinon J, Fabiani JN, et al., Anatomical study of rheumatic tricuspid valvulopathies. Applications to the criticalstudy of various methods of annuloplasty (French). ArchMal Coeur Vaiss 1974; 67(5):497 – 505
[24] Abe T, Tukamoto M, Yanagiya M, et al (1989), “De Vega's annuloplasty for acquired tricuspid disease: early and late result in 110 patients”, Ann Thorac Surg, 48(5), pp. 670-6.
[25] Peterffy A, Jonasson R, Szamori A, et al (1980), “Comparision of Kay's and De Vega's annuloplasty in surgical treatement of tricuspid incompetence. Clinical and haemodynamic results in 62 patients”, Scand J Thorac Cardiovasc Surg, 14 (3), pp. 249-55.
[26] Shemin R Ji (2008), “Tricuspid Valve Disease “Cardiac Surgery in the Adult”, New York: Mc Graw-Hill, pp. 1111-1128.
[27] Dreyfus GD, Raja SG, John Chan KM. Tricuspid leaflet augmentation to address severe tethering in functional tricuspid regurgitation. Eur J Cardiothorac Surg. (2008) 34:908–10. doi: 10.1016/j.ejcts.2008.07.006
[28] Lapenna E, De Bonis M, Verzini A, La Canna G, Ferrara D, Calabrese MC, et al. The clover technique for the treatment of complex tricuspid valve insufficiency: midterm clinical and echocardiographic results in 66 patients. Eur J Cardiothorac Surg. (2010) 37:1297–303. doi: 10.1016/j.ejcts.2009. 12.020
[29] De Bonis M, Del Forno B, Nisi T, Lapenna E, Alfieri O. Tricuspid valve disease: surgical techniques. In: Soliman OI, ten Cate FJ, editors. Practical Manual of Tricuspid Valve Diseases. Cham: Springer (2018). pp. 329–52.
[30] Tang GHL, David TE, Sing SK, et al (2006), "Tricuspid valve repair with an annuloplasty ring results in improved long-term outcomes", Circulation, 114 (suppl I), pp.I-577-I-581.
[31] Xiao XJ, Huang HL, Zhang JF, et al (2004), “Surgical treatment of late tricuspid regurgitation after left cardiac valve replacement”, Heart Lung and Circulation, 13 (1), pp. 65-69.